Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ornithine | hsa00500 | Starch and sucrose metabolism | 2.87E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Ornithine | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Ornithine | hsa04060 | Cytokine-cytokine receptor interaction | 3.95E-02 | 11 | P27930, P08476, Q13651, P25024, P25025, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, CXCR1, CXCR2, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Ornithine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.31E-02 | 7 | P09341, P25024, P25025, P47992, Q9UBD3, Q13651, P01375 | CXCL1, CXCR1, CXCR2, XCL1, XCL2, IL10RA, TNF | More | | Ornithine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Ornithine | hsa04145 | Phagosome | 3.21E-02 | 3 | P60709, P63261, P30511 | ACTB, ACTG1, HLA-F | More | | Ornithine | hsa04151 | PI3K-Akt signaling pathway | 3.06E-02 | 5 | P23229, P48551, P16871, P15336, Q16513 | ITGA6, IFNAR2, IL7R, ATF2, PKN2 | More | | Ornithine | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Ornithine | hsa04520 | Adherens junction | 1.67E-02 | 3 | Q09472, P60709, P63261 | EP300, ACTB, ACTG1 | More | | Ornithine | hsa04530 | Tight junction | 2.77E-02 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Ornithine | hsa04612 | Antigen processing and presentation | 1.81E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Ornithine | hsa04621 | NOD-like receptor signaling pathway | 4.15E-03 | 5 | P52630, P48551, P59665, P59666, Q16513 | STAT2, IFNAR2, DEFA1; DEFA1B, DEFA3, PKN2 | More | | Ornithine | hsa04630 | JAK-STAT signaling pathway | 9.18E-03 | 4 | Q09472, P52630, P48551, P16871 | EP300, STAT2, IFNAR2, IL7R | More | | Ornithine | hsa04640 | Hematopoietic cell lineage | 2.82E-03 | 12 | P13612, P21926, P27930, P15144, P25063, P07766, P09693, P01732, P01730, P09564, P13765, P01375 | ITGA4, CD9, IL1R2, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOB, TNF | More | | Ornithine | hsa04650 | Natural killer cell mediated cytotoxicity | 4.63E-03 | 9 | P01375, P06239, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Ornithine | hsa04657 | IL-17 signaling pathway | 3.52E-02 | 6 | O00463, Q16539, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, CXCL1, MMP9, LCN2, TNF | More | | Ornithine | hsa04658 | Th1 and Th2 cell differentiation | 4.23E-05 | 10 | Q04759, P20963, P09693, Q16539, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD247, CD3G, MAPK14, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | | Ornithine | hsa04659 | Th17 cell differentiation | 9.19E-03 | 8 | Q04759, Q16539, P06239, P13765, Q9UL17, P23771, P09693, P20963 | PRKCQ, MAPK14, LCK, HLA-DOB, TBX21, GATA3, CD3G, CD247 | More | | Ornithine | hsa04660 | T cell receptor signaling pathway | 1.60E-03 | 10 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239, Q16539 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK, MAPK14 | More | | Ornithine | hsa04668 | TNF signaling pathway | 1.81E-02 | 7 | P01375, O00463, Q16539, P18848, P09341, P20749, P14780 | TNF, TRAF5, MAPK14, ATF4, CXCL1, BCL3, MMP9 | More | | Ornithine | hsa04714 | Thermogenesis | 1.75E-03 | 4 | P15336, P60709, P63261, P36542 | ATF2, ACTB, ACTG1, ATP5C1 | More | | Ornithine | hsa04810 | Regulation of actin cytoskeleton | 4.18E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Ornithine | hsa04919 | Thyroid hormone signaling pathway | 3.21E-02 | 3 | P60709, P63261, Q09472 | ACTB, ACTG1, EP300 | More | | Ornithine | hsa04921 | Oxytocin signaling pathway | 2.00E-02 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Ornithine | hsa05030 | Cocaine addiction | 1.92E-02 | 2 | P07101, P15336 | TH, ATF2 | More | | Ornithine | hsa05100 | Bacterial invasion of epithelial cells | 1.92E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Ornithine | hsa05110 | Vibrio cholerae infection | 1.92E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Ornithine | hsa05135 | Yersinia infection | 2.00E-02 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Ornithine | hsa05143 | African trypanosomiasis | 1.92E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Ornithine | hsa05144 | Malaria | 5.11E-03 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | | Ornithine | hsa05146 | Amoebiasis | 9.15E-03 | 7 | P09341, P27930, P01375, P05089, P22694, P12814, P08311 | CXCL1, IL1R2, TNF, ARG1, PRKACB, ACTN1, CTSG | More | | Ornithine | hsa05164 | Influenza A | 5.93E-04 | 5 | Q09472, P48551, P52630, P60709, P63261 | EP300, IFNAR2, STAT2, ACTB, ACTG1 | More | | Ornithine | hsa05165 | Human papillomavirus infection | 1.18E-02 | 5 | P23229, Q09472, P48551, P52630, P30511 | ITGA6, EP300, IFNAR2, STAT2, HLA-F | More | | Ornithine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.63E-02 | 4 | P48551, Q09472, P52630, P30511 | IFNAR2, EP300, STAT2, HLA-F | More | | Ornithine | hsa05202 | Transcriptional misregulation in cancer | 1.95E-02 | 12 | P14780, P27930, Q15744, Q16548, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, LYL1, GADD45A | More | | Ornithine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Ornithine | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Ornithine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.71E-03 | 9 | O95267, P07766, P20963, P09693, P06239, Q04759, Q16539, Q9HC35, P01730 | RASGRP1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, EML4, CD4 | More | | Ornithine | hsa05310 | Asthma | 1.29E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Ornithine | hsa05321 | Inflammatory bowel disease | 6.19E-03 | 5 | P01375, P13765, Q14765, Q9UL17, P23771 | TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Ornithine | hsa05322 | Systemic lupus erythematosus | 4.08E-02 | 7 | O75015, P08246, P08311, P01375, P13765, Q16778, P12814 | FCGR3B, ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Ornithine | hsa05332 | Graft-versus-host disease | 1.32E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Ornithine | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | Ornithine | hsa05410 | Hypertrophic cardiomyopathy | 1.11E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Ornithine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.73E-03 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Ornithine | hsa05414 | Dilated cardiomyopathy | 1.11E-02 | 3 | P23229, P60709, P63261 | ITGA6, ACTB, ACTG1 | More | | Ornithine | hsa05416 | Viral myocarditis | 1.58E-03 | 3 | P30511, P60709, P63261 | HLA-F, ACTB, ACTG1 | More | | |